Lyv Health: Satchu-Burgstone Runner-Up Rock Business Track, 2026 New Venture Competition

Harvard Business School (HBS)
Harvard Business School (HBS)Mar 6, 2026

Why It Matters

If successful, Lyv Health could unlock new revenue streams for roughly 400,000 wellness operators and broaden consumer access to clinical testing and prescription services, while its regulatory expertise may reduce execution risk in a highly regulated space.

Summary

Lyv Health offers a clinical-supervision platform that lets wellness businesses—like health coaches and medspas—order labs, prescriptions and peptides for clients, addressing a market it estimates at $20 billion within the $2 trillion wellness sector. Launched three weeks ago, the startup already has 30 paying business customers and charges platform and transaction fees, projecting roughly $50,000 in gross margin per business per year. The founding team includes a former medtech COO with FDA experience, a repeat health startup founder, a founding engineer and medical advisors from Harvard, Mayo and Johns Hopkins, and the company has raised capital from VCs including Pear and Dharma Fund. Lyv Health positioned itself as a rapid-growth, compliance-focused enabler for businesses lacking clinical infrastructure.

Original Description

Lyv Health is a platform that connects wellness businesses (such as med spas, health coaches, and wellness centers) to clinical services they currently cannot provide but for which they have customer demand — including blood testing, prescriptions, and peptides. Team: Andrea Corleto (MBA 2026), Jennifer Arnold (MS/MBA 2026).

Comments

Want to join the conversation?

Loading comments...